Australia - inglese - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - fentanyl citrate, quantity: 0.4713 mg (equivalent: fentanyl, qty 300 microgram) - tablet - excipient ingredients: mannitol; croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate - abstral is indicated for the management of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - fentanyl citrate, quantity: 0.6248 mg (equivalent: fentanyl, qty 400 microgram) - tablet - excipient ingredients: mannitol; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; microcrystalline cellulose - abstral is indicated for the management of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - fentanyl citrate, quantity: 0.3142 mg (equivalent: fentanyl, qty 200 microgram) - tablet - excipient ingredients: mannitol; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; microcrystalline cellulose - abstral is indicated for the management of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - fentanyl citrate, quantity: 0.1571 mg (equivalent: fentanyl, qty 100 microgram) - tablet - excipient ingredients: mannitol; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; microcrystalline cellulose - abstral is indicated for the management of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 400 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 600 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 800 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 1200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 1600 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.